Active ingredientTerconazoleCat. No. P-T060-001CAS 67915-31-5Family · Pharmaceutical analytical standards
Terconazole
An antifungal of the triazole family, used as a vaginal cream or pessary against vulvovaginal candidiasis; developed in the early 1980s, it was approved in the United States in 1987. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?It is a close relative of ketoconazole and is synthesised in a similar way, but instead of the imidazole ring, with two nitrogen atoms, it carries a triazole ring with three nitrogen atoms.
Go to the active ingredient →Active ingredientTerconazoleCat. No. P-T060-001CAS 67915-31-5
Pharmacopoeial impurityTerconazole EP Impurity ACat. No. P-T060-002CAS 1486497-66-8
Pharmacopoeial impurityTerconazole EP Impurity BCat. No. P-T060-003
Isotopically labelledTerconazole-d8Cat. No. P-T060-004
NitrosamineN,N-Dimethyl-1-nitrosopiperidin-4-amineCat. No. P-T060-005
ImpurityTerconazole Impurity 1Cat. No. P-T060-006CAS 58905-16-1
Impurity4-(4-isopropylpiperazin-1-yl)phenolCat. No. P-T060-007CAS 67914-97-0
ImpurityTerconazole Impurity 2Cat. No. P-T060-008
ImpurityTerconazole Impurity 3Cat. No. P-T060-009
ImpurityTerconazole Impurity 4Cat. No. P-T060-011
ImpurityTerconazole N-OxideCat. No. P-T060-012No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Reference substanceTerconazole CRSEDQM code T0060000Family TerconazoleNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.